🟢 Lantern Pharma is trading 6.6% up in pre-market

Lantern Pharma is trading 6.6% up at $0.70 in pre-market, with no company-specific announcement identified to explain the October 21 move.

• The company’s press-release listing shows its latest release as the October 7 trial update, followed by an October 8 conference announcement.
• Biotech was up 3.64% pre-market, which may be supporting the move but does not establish a direct cause.
• No trading-volume information was provided, and the recent price movement alone does not identify a catalyst.